NTx has developed a fully recombinant cell-free biosynthesis platform to produce mRNA and protein based vaccines and medicines. The manufacturing process offers a number of operational advantages and significantly reduces upfront capital requirements. The company is currently pursuing programs in mRNA vaccines/Mabs, subunit vaccines, novel therapeutics and biosmilars.

Gypsy Bay Genomics was founded to commercialize a novel molecular diagnostic for detecting cervical and other HPV related precancer and cancer. The test employs innovative molecular pathology technology to improve the diagnostic and prognostic results of DNA screening. Our objective is to deliver higher quality testing, at lower cost, with reduced cycle time. We believe this technology will enable healthcare providers to offer greater global access to screening for the prevent HPV cancers.

Lead identification, evaluation & negotiation of strategic and product collaborations for immuno-oncology, immunology and infectious disease therapeutic areas.

Developed and implemented new business partnership model for collaboration among international vaccine manufacturers and government ministries to grow our vaccine business and expand global access. Oversee cross divisional team responsible for the identification of partners, structuring of agreements, supply of commercial vaccine, transfer of technology and materials, and financial results.Accomplishments:• Negotiated and implemented partnership with largest Indian manufacturer for global commercialization and distribution of conjugate vaccine.• Negotiated and implemented product development partnership for cervical cancer and hepatitis A vaccines to Brazilian manufacturer.• Brazil partnership grew the subsidiary’s revenue to first position among global pharmaceutical firms in market ranking• Led cross functional team to complete playbook to standardize practices for public-private partnerships and scale business model

Led global commercial strategy development for early stage vaccine products (Discovery to Phase IIb) across adult, adolescent and pediatric portfolio. Responsibilities included preparing business cases for new targets, guidance for R&D on product profiles and marketing requirements, organizing advisory boards with external scientific leaders and global health advocates to identify product development and customer needs, and commercial assessments of product and technology licensing opportunities.Accomplishments:• Co-led pipeline assessment for new targets and received approval for five new or improved vaccines for R&D• Successfully licensed and acquired vaccine candidates for pre-clinical development• Established business strategy for novel vaccine delivery and stabilization technology• Secured proof of concept funding for new lyophilization technology• Recruited marketing professionals for department

Led U.S. launch of Gardasil and delivered over $1.0 billion of revenue in first six months of distribution. Set thought leader, healthcare professional, consumer and managed care strategies. Oversaw branding, marketing and promotion plan development and execution. Prepared pricing and reimbursement strategy recommendations. Provided commercial input during FDA label negotiations and ACIP Policy making. P&L responsibility.Accomplishments:• Multiple industry awards for launch branding and promotional campaigns • First vaccine to receive FDA accelerated review and approval.• “Tell Someone” disease awareness campaign for consumers.• Branded D-T-C campaign for adolescent and parent product awareness• Exceeded all provider adoption, insurance coverage and financial objectives.• Pharmaceutical Executive magazine Brand of the Year 2006• Built marketing team for launch

Developmental assignment leading dermatology business including marketing and specialty salesforce.

Led marketing team responsible for U.S. physician, managed care, and consumer promotion of Singular (est Revenue ~$1 billion). Set thought leader, healthcare professional, consumer and managed care strategies. Oversaw branding, marketing and promotion plan development and execution. P&L responsibility.Accomplishments:• Grew annual revenues from under $100mm to over $1.0 billion• Successful D-T-C campaign to create brand awareness among consumers• Oversaw thought leader advisory boards for asthma and allergic rhinitis• Marketing point for JV formation (Schering Plough)• Launched Allergic Rhinitis indication

Led Sales & marketing for Philippine subsidiary. Managed business unity of 187 sales, marketing, training, advocacy development, and marketing operations professionals.Accomplishments:• Transitioned organization from stand-alone distributor to wholly owned company subsidiary • Trained business unit on company’s strategy and planning processes• Revenue growth over 20% (yoy)• Installed budgeting process to manage P&L for local business units